Company news

Xbrane Biopharma AB news in 2025

Xbrane Biopharma AB's news releases, calls and decks from 2025, newest first.

View company

Xbrane Biopharma resolves to issue 420,517 warrants to Fenja Capital II A/S under the conditional financing solution

November 24, 2025

XBRANE updates on timing for resubmission of the BLA for its ranibizumab biosimilar candidate to FDA

November 19, 2025

Xbrane Enters Into Conditional Financing Deal Related To Ranibizumab Biosimilar

October 27, 2025

Xbrane Biopharma releases Interim Report for January-September 2025

October 24, 2025

Calls in 2025

Decks in 2025